Similar articles

• Species differences in the metabolism and regulation of gene expression by conjugated linoleic acid.

  Moya-Camarena SY, Belury MA. Moya-Camarena SY, et al. Nutr Rev. 1999 Nov;57(11):336-40. doi: 10.1111/j.1753-4887.1999.tb06910.x. Nutr Rev. 1999. PMID: 10628184 Review.
• Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells.

  Masugi J, Tamori Y, Kasuga M. Masugi J, et al. Biochem Biophys Res Commun. 1999 Oct 14;264(1):93-9. doi: 10.1006/bbrc.1999.1488. Biochem Biophys Res Commun. 1999. PMID: 10527847
• PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression.

  Chen NG, Sarabia SF, Malloy PJ, Zhao XY, Feldman D, Reaven GM. Chen NG, et al. Biochem Biophys Res Commun. 1999 Oct 5;263(3):718-22. doi: 10.1006/bbrc.1999.1437. Biochem Biophys Res Commun. 1999. PMID: 10512746
• Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.

  Wiesenberg I, Chiesi M, Missbach M, Spanka C, Pignat W, Carlberg C. Wiesenberg I, et al. Mol Pharmacol. 1998 Jun;53(6):1131-8. Mol Pharmacol. 1998. PMID: 9614218
• Functional activation of peroxisome proliferator-activated receptor alpha (PPARalpha) by environmental chemicals in relation to their toxicities.

  Nakajima T, Ichihara G, Kamijima M, Itohara S, Aoyama T. Nakajima T, et al. Nagoya J Med Sci. 2002 Nov;65(3-4):85-94. Nagoya J Med Sci. 2002. PMID: 12580534 Review.